294 related articles for article (PubMed ID: 23522858)
1. Diagnosis of unknown sarcoidosis associated to erythema nodosum with 18F-FDG PET/CT.
Rampin L; Musto A; Marzola MC; Tadayyon S; Ferretti A; Chondrogiannis S; Grassetto G; Rubello D
Rev Esp Med Nucl Imagen Mol; 2013; 32(3):190-2. PubMed ID: 23522858
[TBL] [Abstract][Full Text] [Related]
2. Use of whole-body FDG PET-CT to aid in the diagnosis of occult sarcoidosis.
Tannen BL; Ghesani NV; Frohman L; Eichler JD; Maldjian PD; Chu DS
Ocul Immunol Inflamm; 2008; 16(1):25-7. PubMed ID: 18379938
[TBL] [Abstract][Full Text] [Related]
3. The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review.
Treglia G; Annunziata S; Sobic-Saranovic D; Bertagna F; Caldarella C; Giovanella L
Acad Radiol; 2014 May; 21(5):675-84. PubMed ID: 24703482
[TBL] [Abstract][Full Text] [Related]
4. FDG PET/CT showing erythema nodosum associated with tuberculous lymphadenitis.
Chen X; Lu H; Gao Y
Clin Nucl Med; 2013 Dec; 38(12):992-3. PubMed ID: 24152619
[TBL] [Abstract][Full Text] [Related]
5. Whole-body 18FDG PET-CT imaging of systemic sarcoidosis: ophthalmic oncology and uveitis.
Shulman JP; Latkany P; Chin KJ; Finger PT
Ocul Immunol Inflamm; 2009; 17(2):95-100. PubMed ID: 19412870
[TBL] [Abstract][Full Text] [Related]
6. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
7. Comparison of early (60 min) and delayed (180 min) acquisition of 18F-FDG PET/CT in large vessel vasculitis.
Martínez-Rodríguez I; del Castillo-Matos R; Quirce R; Jiménez-Bonilla J; de Arcocha-Torres M; Ortega-Nava F; Rubio-Vassallo A; Martínez Amador N; Ibáñez Bravo S; Carril JM
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):222-6. PubMed ID: 23688731
[TBL] [Abstract][Full Text] [Related]
8. Incidental finding of an endobronchial tumor by 18F-FDG PET/CT.
Navales I; Garcia JR; Alvarez-Moro FJ; Navarro A; Escobar I; Lomeña F
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):271-2. PubMed ID: 23046638
[No Abstract] [Full Text] [Related]
9. F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.
Simonen P; Lehtonen J; Kandolin R; Schildt J; Marjasuo S; Miettinen H; Airaksinen J; Vihinen T; Tuohinen S; Haataja P; Kupari M
Am J Cardiol; 2015 Nov; 116(10):1581-5. PubMed ID: 26411357
[TBL] [Abstract][Full Text] [Related]
10. Giant cell arteritis on 18F-FDG PET/CT.
Heston TF; Szabo Z
Clin Physiol Funct Imaging; 2009 Sep; 29(5):382-4. PubMed ID: 19522856
[TBL] [Abstract][Full Text] [Related]
11. [Incidental detection of Paget disease on ¹⁸F-FDG PET/CT scan in a patient with rectal cancer].
Mena LM; Hernández AC; Gallego M; Martínez T; Contreras JF
Rev Esp Med Nucl Imagen Mol; 2013 Mar; 32(2):117-8. PubMed ID: 23177337
[No Abstract] [Full Text] [Related]
12. Refractory polymyalgia rheumatica as presenting manifestation of large-vessel vasculitis associated to sarcoidosis. Successful response to adalimumab.
Bejerano C; Blanco R; González-Vela C; Agüero R; Carril JM; González-Gay MA
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S94-7. PubMed ID: 22410180
[TBL] [Abstract][Full Text] [Related]
13. F-18 FDG PET/CT for detecting bone and bone marrow involvement in sarcoidosis patients.
Mostard RL; Prompers L; Weijers RE; van Kroonenburgh MJ; Wijnen PA; Geusens PP; Drent M
Clin Nucl Med; 2012 Jan; 37(1):21-5. PubMed ID: 22157023
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of sarcoidosis-lymphoma syndrome lesions: a case report on the use of two different positron emission tomography tracers.
Yudistiro R; Arisaka Y; Tokue A; Nakajima T
BMC Med Imaging; 2016 Jan; 16():1. PubMed ID: 26746426
[TBL] [Abstract][Full Text] [Related]
15. Use of integrated FDG-PET/CT in sarcoidosis.
Krüger S; Buck AK; Mottaghy FM; Pauls S; Schelzig H; Hombach V; Reske SN
Clin Imaging; 2008; 32(4):269-73. PubMed ID: 18603181
[TBL] [Abstract][Full Text] [Related]
16. Interest of [18F]FDG PET/CT for treatment efficacy assessment in aggressive phenotype of sarcoidosis with special emphasis on sinonasal involvement.
Imperiale A; Riehm S; Braun JJ
Q J Nucl Med Mol Imaging; 2013 Jun; 57(2):177-86. PubMed ID: 23598684
[TBL] [Abstract][Full Text] [Related]
17. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
[TBL] [Abstract][Full Text] [Related]
18. Outcome of clinical stage III melanoma patients with FDG-PET and whole-body CT added to the diagnostic workup.
Niebling MG; Bastiaannet E; Hoekstra OS; Bonenkamp JJ; Koelemij R; Hoekstra HJ
Ann Surg Oncol; 2013 Sep; 20(9):3098-105. PubMed ID: 23612885
[TBL] [Abstract][Full Text] [Related]
19. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance.
Israel O; Yefremov N; Bar-Shalom R; Kagana O; Frenkel A; Keidar Z; Fischer D
J Nucl Med; 2005 May; 46(5):758-62. PubMed ID: 15872347
[TBL] [Abstract][Full Text] [Related]
20. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]